Mizuho lowered the firm’s price target on Molina Healthcare (MOH) to $376 from $382 and keeps an Outperform rating on the shares. The firm updated the company’s model post the Q4 report. Its estimates reflect a continued elevated utilization environment.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MOH:
- Early notable gainers among liquid option names on February 27th
- Molina Healthcare price target lowered to $340 from $370 at Truist
- Molina Healthcare’s Growth at Risk: Navigating Restrictive Credit Covenants
- Molina Healthcare price target lowered to $342 from $378 at TD Cowen
- Buy Rating for Molina Healthcare: Strategic Growth Amidst Challenges